Hexagon Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $992K | Sell |
|
|||||
|
2024
Q4 | $872K | Sell |
|
|||||
|
2024
Q3 | $799K | Sell |
|
|||||
|
2024
Q2 | $701K | Buy |
|
|||||
|
2024
Q1 | $638K | Sell |
|
|||||
|
2023
Q4 | $766K | Sell |
|
|||||
|
2023
Q3 | $722K | Buy |
|
|||||
|
2023
Q2 | $648K | Sell |
|
|||||
|
2023
Q1 | $732K | Buy |
|
|||||
|
2022
Q4 | $756K | Sell |
|
|||||
|
2022
Q3 | $706K | Buy |
|
|||||
|
2022
Q2 | $329K | Buy |
|
|||||
|
2022
Q1 | $216K | Buy |
|
|||||
|
2021
Q4 | $154K | Hold |
|
|||||
|
2021
Q3 | $148K | Hold |
|
|||||
|
2021
Q2 | $146K | Buy |
|
|||||
|
2021
Q1 | $124K | Buy |
|
|||||
|
2020
Q4 | $82K | Sell |
|
|||||
|
2020
Q3 | $100K | Buy |
|